...2018. ViralClear Pharmaceuticals Inc. said Tony Zook will join the board. Zook was president of MedImmune Inc....

...a letter Mott sent to BioCentury. Prior to NEA, Mott had a 16-year tenure at MedImmune Inc....

...JNJ's Janssen unit is collaborating with MeiraGTx to develop gene therapies for ophthalmic indications; AZ's MedImmune Inc....

...joined as CSO. He was VP of R&D and head of oncology research at the MedImmune Inc....

...Inc. division of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), as well as a veteran of MedImmune Inc....

...investment from Life Sciences Fund Amsterdam, and revenues from licensing deals with partners including the MedImmune Inc....

...and CEO Peter Greenleaf and CSO Peter Kiener had worked with Mott and Machielse at MedImmune Inc....

...and commercialize benralizumab outside of Japan and certain Asian countries through its 2007 acquisition of MedImmune Inc....

...Flow Advaxis Inc. (NASDAQ:ADXS) gained $0.28 (10%) to $2.92 last week after partnering with the MedImmune Inc....

...Advaxis Inc. (NASDAQ:ADXS) and the MedImmune Inc. unit of AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered in a non-exclusive...